Antifibrinolytic therapy (tranexamic acid or epsilon aminocaproic acid) vs placebo
Adverse events of antifibrinolytic agents · People with a haematological disorder
1 finding from 1 review
- Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders 2016 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 74 participantsVery low